Haemonetics Corporation is a global medical technology company focused on delivering innovative hematology products and solutions. The company's business model is structured around three primary segments: Plasma, Blood Center, and Hospital. The Plasma segment provides automated plasma collection systems, donor management software, and related disposables (such as the NexSys PCS system) that optimize operations for plasma collection centers. The Blood Center segment offers technologies that improve operational efficiency and ensure blood safety during the collection of in-demand blood components. The Hospital segment provides a suite of technologies designed to advance patient care, including the TEG viscoelastic analyzer systems for hemostasis management, Cell Saver autologous blood recovery systems, and vascular closure products like the VASCADE platform. Haemonetics generates revenue through the sale of capital equipment, single-use disposables, and software solutions. Geographically, the company operates globally, deriving significant revenue from North America, Europe, and Asia. Its competitive position is strengthened by its end-to-end solutions that address critical medical needs across the blood management continuum, from donor collection to surgical transfusion and vascular closure.
